cold sore

(redirected from oral herpes)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to oral herpes: canker sore, Oral thrush, angular cheilitis

cold sore:

see herpes simplexherpes simplex
, an acute viral infection of the skin characterized by one or more painful, itching blisters filled with clear fluid. It is caused by either of two herpes simplex viruses: Type 1, herpes labialis,
..... Click the link for more information.
.

cold sore

a cluster of blisters at the margin of the lips that sometimes accompanies the common cold, caused by a viral infection
References in periodicals archive ?
Oral herpes is a leading cause of corneal blindness worldwide.
The vaccine didn't protect men, regardless of whether they had oral herpes.
The Oral Herpes Disease and Therapy Review provides an overview of oral herpes, with incidence and prevalence numbers, percentages and trends for major countries worldwide, and an overview of treatment.
adult population suffers from herpes simplex virus 1, or oral herpes virus, which causes cold sores.
The former funds, raised exclusively from private investors, are to be used to further the Company's two Phase 2 IND clinical trials currently in progress for influenza and recurrent oral herpes.
In a breakthrough discovery, SPI has identified SPH-001 as a very effective therapy for the treatment of genital and oral herpes.
announced today that it has initiated a Phase 1/2a clinical evaluation of its novel therapeutic agent for treating recurrent oral herpes infections.
announced today that the FDA has approved its IND for a Phase 1/2a clinical evaluation of BTL-TML-HSV, a novel therapeutic agent for treating recurrent oral herpes infections.
Much of the higher net loss reported for fiscal 1997 was attributable to increased costs incurred in connection with Phase 3 clinical trials of n-docosanol 10% cream (LIDAKOL(R)) as a treatment for oral herpes that were completed during the fiscal year and the filing of the New Drug Application for this product that was completed in December 1997.
With this NDA submission, LIDAK is seeking approval for marketing LIDAKOL (n-docosanol 10% cream) as a topical treatment for recurrent oral herpes (cold sores or fever blisters).
Despite high unmet need, the market for the small molecules used to manage conditions such as genital and oral herpes, genital warts, cytomegalovirus retinitis and pneumonia or shingles has been neglected compared with the successfully promoted immunizations for varicella in children, zoster in adults, or human papilloma virus in adolescents.